MedTrace Logo

Evaluation of the Nucleus Hybrid™ L24 Cochlear Implant System

NCT00678899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2015-07-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy associated with the provision of acoustic and electric sound processing to individuals who demonstrate significant residual low-frequency hearing and profound high-frequency (above 1500 Hz) sensorineural hearing loss. Delivery of acoustic-electric stimulation will be provided by the Nucleus Hybrid L24 cochlear implant system.

Conditions

  • Sensorineural Hearing Loss

Interventions

DEVICE

Nucleus Hybrid L24

Implantation with Nucleus Hybrid L24 cochlear implant

Sponsors & Collaborators

  • Cochlear

    lead INDUSTRY

Principal Investigators

  • John T Roland, MD · NYU MEDICAL CENTER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2012-06-30
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00678899 on ClinicalTrials.gov